Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / *W EXP 08/27/202
-
Total 13F shares
-
799,708
-
Share change
-
-66,564
-
Total reported value
-
$333,447
-
Price per share
-
$0.42
-
Number of holders
-
9
-
Value change
-
-$32,962
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) as of Q4 2023
As of 31 Dec 2023,
Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
799,708 shares.
The largest 9 holders included
JOSH ARNOLD INVESTMENT CONSULTANT, LLC, LPL Financial LLC, Walleye Capital LLC, JANE STREET GROUP, LLC, Sio Capital Management, LLC, LMR Partners LLP, CVI Holdings, LLC, WOLVERINE ASSET MANAGEMENT LLC, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.